Pulmatrix Days Of Sales Outstanding from 2010 to 2024

PULM Stock  USD 6.64  0.70  9.54%   
Pulmatrix Days Of Sales Outstanding yearly trend continues to be very stable with very little volatility. Days Of Sales Outstanding is likely to drop to 44.09. During the period from 2010 to 2024, Pulmatrix Days Of Sales Outstanding quarterly data regression pattern had sample variance of  10,663 and median of  146.18. View All Fundamentals
 
Days Of Sales Outstanding  
First Reported
2010-12-31
Previous Quarter
46.41271581
Current Value
44.09
Quarterly Volatility
103.26230656
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Pulmatrix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pulmatrix's main balance sheet or income statement drivers, such as Interest Expense of 185.2 K, Other Operating Expenses of 16.9 M or Research Development of 10.3 M, as well as many indicators such as Price To Sales Ratio of 0.88, Dividend Yield of 0.1 or PTB Ratio of 0.4. Pulmatrix financial statements analysis is a perfect complement when working with Pulmatrix Valuation or Volatility modules.
  
Check out the analysis of Pulmatrix Correlation against competitors.
To learn how to invest in Pulmatrix Stock, please use our How to Invest in Pulmatrix guide.

Latest Pulmatrix's Days Of Sales Outstanding Growth Pattern

Below is the plot of the Days Of Sales Outstanding of Pulmatrix over the last few years. It is Pulmatrix's Days Of Sales Outstanding historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pulmatrix's overall financial position and show how it may be relating to other accounts over time.
Days Of Sales Outstanding10 Years Trend
Slightly volatile
   Days Of Sales Outstanding   
       Timeline  

Pulmatrix Days Of Sales Outstanding Regression Statistics

Arithmetic Mean120.56
Geometric Mean56.56
Coefficient Of Variation85.65
Mean Deviation76.94
Median146.18
Standard Deviation103.26
Sample Variance10,663
Range331
R-Value(0.32)
Mean Square Error10,344
R-Squared0.1
Significance0.25
Slope(7.27)
Total Sum of Squares149,283

Pulmatrix Days Of Sales Outstanding History

2024 44.09
2023 46.41
2022 78.04
2021 4.73
2020 2.43
2018 332.24
2017 1.09

About Pulmatrix Financial Statements

Pulmatrix investors utilize fundamental indicators, such as Days Of Sales Outstanding, to predict how Pulmatrix Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Days Of Sales Outstanding 46.41  44.09 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Pulmatrix is a strong investment it is important to analyze Pulmatrix's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pulmatrix's future performance. For an informed investment choice regarding Pulmatrix Stock, refer to the following important reports:
Check out the analysis of Pulmatrix Correlation against competitors.
To learn how to invest in Pulmatrix Stock, please use our How to Invest in Pulmatrix guide.
You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pulmatrix. If investors know Pulmatrix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pulmatrix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.64)
Revenue Per Share
3.119
Quarterly Revenue Growth
(0.16)
Return On Assets
(0.30)
Return On Equity
(0.59)
The market value of Pulmatrix is measured differently than its book value, which is the value of Pulmatrix that is recorded on the company's balance sheet. Investors also form their own opinion of Pulmatrix's value that differs from its market value or its book value, called intrinsic value, which is Pulmatrix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pulmatrix's market value can be influenced by many factors that don't directly affect Pulmatrix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pulmatrix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pulmatrix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pulmatrix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.